Press release
Recombinant Human Endostatin Market Gains Momentum with Increasing Research Investments and Advanced Genetic Engineering Technologies
Recombinant Human Endostatin Market
According to the latest research by InsightAce Analytic, the Global Recombinant Human Endostatin Market is valued at US$ 133.3 Mn in 2023, and it is expected to reach US$ 249.4 Billion by 2031, with a CAGR of 8.3% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2597
Recombinant human endostatin is a bioengineered derivative of endostatin, a naturally occurring human protein recognized for its capacity to inhibit angiogenesis-the process of new blood vessel formation. Produced through recombinant DNA technology, this therapeutic agent is primarily employed in oncology for its targeted anti-tumor properties. The market for recombinant human endostatin is witnessing steady growth, propelled by the rising global prevalence of cancer, continuous advancements in biotechnological research, and significant investments in the development of precision oncology therapies.
Additionally, supportive government initiatives aimed at improving the affordability of cancer treatments and expanding access to innovative therapeutics are contributing to market expansion. Ongoing research exploring new clinical applications of recombinant human endostatin further strengthens its market potential. However, the industry continues to face challenges, including high production and development costs, as well as the limited availability of approved endostatin-based drugs. Despite these constraints, the growing demand for effective, targeted, and minimally invasive cancer therapies is expected to sustain and accelerate market growth over the forecast period.
List of Prominent Players in the Recombinant Human Endostatin Market:
• Thermo Fisher Scientific
• PeproTech
• Pfizer Inc.,
• Novus Biologicals,
• Biocon,
• Yantai Medgenn Ltd.,
• FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.,
• Onyx Pharmaceuticals, Inc.,
• Genexine, Inc.,
• Hetero.,
• Intas Pharmaceuticals Ltd.,
• Novartis AG.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics
Drivers:
The recombinant human endostatin market is experiencing sustained growth, primarily driven by the escalating global demand for advanced cancer therapeutics and the increasing prevalence of oncology-related diseases. Continuous advancements in biotechnology and genetic engineering have significantly improved the scalability, yield, and production efficiency of recombinant human endostatin, thereby supporting broader clinical adoption.
The therapeutic effectiveness of recombinant human endostatin in inhibiting angiogenesis and suppressing tumor progression is being reinforced by positive outcomes from ongoing research and clinical trials. Moreover, increased investment in oncology research, coupled with supportive government initiatives and favorable regulatory frameworks, is further fostering market expansion.
Challenges:
Despite its promising potential, the recombinant human endostatin market faces several key challenges. High manufacturing costs and complex bioproduction processes limit affordability and accessibility, particularly in developing regions. Additionally, stringent regulatory approval procedures and lengthy commercialization timelines pose obstacles to market entry.
Limited awareness among healthcare professionals and patients regarding the clinical advantages of recombinant human endostatin further constrains its adoption. Furthermore, the availability of alternative cancer treatment modalities, including targeted biologics and immunotherapies, intensifies competition and may moderate the pace of market growth.
Regional Trends:
North America is projected to maintain a leading position in the recombinant human endostatin market, supported by a high cancer incidence rate, strong investment in research and development, and a well-established healthcare infrastructure. The region's emphasis on precision medicine and biopharmaceutical innovation continues to drive market progress.
Europe also represents a significant market, characterized by comprehensive healthcare systems, robust funding for biotechnological research, and proactive government support for advanced therapeutic development. The presence of major pharmaceutical and biotechnology companies, along with ongoing clinical advancements, is expected to further enhance market expansion across the region.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2597
Recent Developments:
• In June 2024, Thermo Fisher Scientific Inc announced the KingFisherTM PlasmidPro Maxi Processor, the only fully automated maxi-scale plasmid DNA (pDNA) purification machine. PlasmidPro automates small and maxi-scale purification and delivers high-purity plasmids without column preparation or intervention. This is the latest addition to the Thermo Scientific KingFisher instrument portfolio, which includes many plasmid DNA extraction tools to improve efficiency and consistency.
• In June 2024, Thermo Fisher Scientific Inc.'s PPD clinical research division expanded its central laboratory operations in Kentucky. This expansion is aimed at speeding up the delivery of medicines that work and are safe to patients by pharmaceutical and biotech companies.
Segmentation of Recombinant Human Endostatin Market-
By Type-
• Purity 95%
• Others
By Application-
• Medical Care
• Scientific Research
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/recombinant-human-endostatin-market-44409/2597
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Recombinant Human Endostatin Market Gains Momentum with Increasing Research Investments and Advanced Genetic Engineering Technologies here
News-ID: 4248322 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Gene Switch / Molecular Switch Market Gains Momentum as Biotech Firms Drive Inno …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Gene Switch / Molecular Switch Market"- Distribution by Application Area (Management of Treatment Related Toxicity, Regulation of Gene Expression and Other Applications), Type of Target Therapy (CAR T Cell Therapy, Gene Therapy and Other Therapies), Type of Payment Model Employed (Upfront Payments and Milestone Payments),Industry Trends, and Global Forecasts, 2022-2035 And Segment Revenue and Forecast To…
ADME Toxicology Testing Market Experiences Surge as Regulatory Standards Strengt …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "ADME Toxicology Testing Market"- By Type of Services (Absorption, Distribution, Metabolism, Excretion), Type of Assays(Batch / Fed-Batch, Continuous), Type of Molecule (Biologics, Small Molecules), End User(Pharmaceutical and Biotechnology Companies, Academic / Research Institutes), Therapeutic Areas(Blood Disorder, Cardiovascular Disorder, Gastrointestinal and Vascular Disorder, Hormonal Disorder, Infectious Diseases, Immunological Disorders, Mental Disorders, Metabolic Disorders, Neurological Disorders, Oncology…
Cobalt Free Batteries Market Set for Expansion Owing to Cost Reduction Strategie …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Cobalt Free Batteries Market"-, By Type (Lithium Ferrous (Iron) Phosphate Battery, Lead Acid Batteries), By End Use (Electronic Vehicles, Energy Storage), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
The Cobalt Free Batteries Market is estimated to reach over USD 4.10 billion by 2031, exhibiting a CAGR of 14.4% during the forecast period.
Get…
Solar-Powered Microbes Market Growth Boosted by Expanding Applications in Dairy …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Solar-Powered Microbes Market Size, Share & Trends Analysis Report By End-Use Industry (Food (Bakery and Confectionery, Dairy, Fruits and Vegetables, Beverages, Meat), Feed), By Type (Bacteria, Yeast, Molds)- Market Outlook And Industry Analysis 2031"
The Global Solar-Powered Microbes Market is valued at US$ 7.50 Bn in 2023, and it is expected to reach US$ 11.75 Bn…
More Releases for Recombinant
Recombinant Chemicals Market Expands with Growing Adoption of Recombinant DNA an …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Recombinant Chemicals Market - (By Product Type (Recombinant Proteins, Recombinant DNAs, Recombinant Peptides, Others), By Technology (Microbial Expression Systems, Mammalian Cell Expression Systems, Yeast Expression Systems, Insect Cell Expression Systems, Cell-free Expression Systems), By Application (Drug Development, Vaccine Production, Therapeutics, Cell Line Development, Agriculture, Food and Beverage, Others)), Trends, Industry Competition Analysis, Revenue and Forecast…
Recombinant Collagen Market Size and Forecast
Recombinant Collagen Market size was valued at USD 0.9 Billion in 2022 and is projected to reach USD 1.8 Billion by 2030, growing at a CAGR of 9.0% from 2024 to 2030.
Recombinant Collagen Market Outlook and Investment Analysis
Top companies
Giant Biogene Holding, Avantor, ProColl, Merck, ACROBiosystems, Wuhan Fine Biotech, Shanxi Jinbo Bio-Pharmaceutical, Jiangsu Jland Biotech, Jiangsu Trautec Medical Technology, OriGene Technologies
Recombinant Collagen Market: Trends & Investment Analysis
Market Growth: The recombinant collagen…
Global Recombinant Cell Culture Supplements Market Size - By Product Type(Recomb …
Recombinant Cell Culture Supplements Market Insights: Trends, Drivers, and Outlook 2024 - 2031
Recombinant Cell Culture Supplements Market Scope: Unveiling Today's Trends
Recombinant Cell Culture Supplements are specialized products designed to enhance growth and productivity in cells used for research and bioproduction.
The market for these supplements is experiencing substantial growth, driven by the rising demand for biopharmaceuticals and advancements in biotechnology. Increasing investments in research and development activities also contribute to market…
Global Recombinant Vaccines Market Segmentation, Business Analysis and Forecast …
Global Recombinant Vaccines Market Analysis 2022-2028 Report provides strategists, marketers and senior management with the critical information they need to assess the global Recombinant Vaccines Market as it emerges from the Covid-19 shut down. The impact of Coronavirus (COVID-19) on global market has reinforced many trends already shaping the industry pre COVID-19, There is a long-term trend towards the repositioning of players as entertainment providers on multiple platforms.
This study provides…
Recombinant Protein Market Size, Share | Recombinant Protein Industry Future Gro …
Global Recombinant Protein Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Recombinant Protein Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,…
Recombinant Proteins Market 2022 | Recombinant Proteins Market: Global Industry …
Recombinant proteins play an imperative role in treating various diseases, such as hemophilia. Majority of the recombinant proteins used are human proteins, in order to compensate the functional proteins in vivo defects by increasing the protein function in a body. This Research Report Insights analyzes the expansion of global recombinant protein market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.
The next…
